Bob Lechleider
About Bob Lechleider
Bob Lechleider Chief Medical Officer
Bob Lechleider currently holds the position of Chief Medical Officer at Immunome. Before joining Immunome, Bob served as the Chief Medical Officer at OncoResponse. His extensive experience in clinical development and medical leadership underscores his capability in directing medical strategies and overseeing clinical trials.
Bob Lechleider Education
Bob Lechleider earned an A.B. from Princeton University. He then proceeded to receive his M.D. from the University of Illinois College of Medicine at Chicago. His educational background laid a strong foundation for his professional journey in the medical and biotechnology fields.
Bob Lechleider Clinical Residency and Medical Oncology
Bob Lechleider completed his clinical residency in internal medicine at Beth Israel-Deaconess Medical Center in Boston. Following this, he completed a residency in medical oncology at the National Cancer Institute in Bethesda. These residencies equipped him with specialized knowledge and practical expertise in internal medicine and oncology.
Bob Lechleider Biotechnology Career
Bob Lechleider began his career in the biotechnology sector at MedImmune. He furthered his career by holding positions at Human Genome Sciences and Macrogenics. His significant contributions to the field include serving as the Senior Vice President of clinical development for Seagen, where he played a crucial role in advancing clinical programs and therapeutic strategies.